,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,541575,5955,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,541575,5955,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,541575,5955,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,541575,5955,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,541575,5955,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,541575,5955,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,45745,4,4,,103355242,5955,Active,,,0.00033,IC50,Inhibitory activity of compound for AA8 cells to reduce cell density by 50% (exposed to compound for 4 hours),Confirmatory,2909741.0,
7,229741,3,3,,103355242,5955,Unspecified,,,,,Hypersensitivity factor (HF) of IC50 (AA8) / IC50 (EM-9) of compound for repair deffective mutants,Other,2909741.0,
8,229742,3,3,,103355242,5955,Unspecified,,,,,Hypersensitivity factor (HF) of IC50 (AA8) / IC50 (UV-4) of compound for repair deffective mutants,Other,2909741.0,
9,229743,3,3,,103355242,5955,Unspecified,,,,,Hypersensitivity factor (HF) of IC50 (AA8) / IC50 (UV-5) of compound for repair deffective mutants,Other,2909741.0,
10,319212,3,4,,103355242,5955,Unspecified,,,,,Genotoxicity against Salmonella Typhimurium TA 1535/pSK1002 assessed as induction of umu operon expression,Other,18341274.0,
11,319213,3,4,,103355242,5955,Unspecified,,,,,Genotoxicity against Salmonella Typhimurium TA 1535/pSK1002 assessed as induction of umu operon expression in presence of rat liver S9 fraction,Other,18341274.0,
12,319214,3,4,,103355242,5955,Unspecified,,,,,Genotoxicity against Salmonella Typhimurium NM2009 assessed as induction of umu operon expression,Other,18341274.0,
13,319215,3,4,,103355242,5955,Unspecified,,,,,Genotoxicity against Salmonella Typhimurium NM2009 assessed as induction of umu operon expression in presence of rat liver S9 fraction,Other,18341274.0,
14,450173,3,4,,103355242,5955,Unspecified,,,,,Mutagenic activity in Salmonella Typhimurium at 2.16 uM after 60 hrs by Ames test in absence of human S9 fraction,Other,19261478.0,
15,450174,3,4,,103355242,5955,Unspecified,,,,,Mutagenic activity in Salmonella Typhimurium TA98 at 2.16 uM after 60 hrs by Ames test in absence of human S9 fraction,Other,19261478.0,
16,537733,2,3,,103355242,5955,Active,,,,,Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u,Other,20739103.0,
17,537734,5,2,,103355242,5955,Unspecified,,,,,Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay,Other,20739103.0,
18,537735,2,3,,103355242,5955,Active,,,,,Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u,Other,20739103.0,
19,537736,5,2,,103355242,5955,Unspecified,,,,,Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay,Other,20739103.0,
20,554980,2,9,,103355242,5955,Inactive,121732831.0,,,,Inhibition of Candida krusei ABC1 expressed in Saccharomyces cerevisiae isolate ADdelta at 4 nM,Other,19015352.0,
21,661623,1,2,,103355242,5955,Unspecified,,,,,Mutagenic activity in Salmonella typhimurium TA 98 assessed as increase in revertants at 5 ug/plate after 48 hrs by Ames test relative to control,Other,22542015.0,
22,693044,1,2,,103355242,5955,Unspecified,,,,,Genotoxicity in human lymphocytes assessed as micronucleated binucleate cells level at 2.5 ug/mL incubated for 20 hrs measured post 28 hrs recovery in absence of rat liver S9 fraction (Rvb = 0.3%),Other,21353728.0,
23,693071,1,2,,103355242,5955,Unspecified,,,,,Genotoxicity in human lymphocytes assessed as micronucleated binucleate cells level at 5 ug/mL incubated for 20 hrs measured post 28 hrs recovery in absence of rat liver S9 fraction (Rvb = 0.4%),Other,21353728.0,
24,1093797,1,2,,103355242,5955,Unspecified,,,,,Ratio of CR50 for wild type Bacillus subtilis H17 to CR50 for recombination-deficient Bacillus subtilis M45,Other,,
25,1093798,1,2,,103355242,5955,Unspecified,,,,,Genotoxicity in recombination-deficient Bacillus subtilis M45 assessed as growth inhibition,Other,,
26,1093799,1,2,,103355242,5955,Unspecified,,,,,Genotoxicity in wild type Bacillus subtilis H17 assessed as growth inhibition,Other,,
27,1134822,1,1,,103355242,5955,Unspecified,,,,,Carcinogenicity in mouse assessed as tumor development administered sc in left groin 6 times at 10-day interval,Other,102791.0,
28,1134823,2,1,,103355242,5955,Unspecified,,,,,"Lipophilicy, log P of the compound",Other,102791.0,
29,1195600,1,1,,103355242,5955,Unspecified,,,,,Genotoxicity in rec-positive Bacillus subtilis H17 at 2 ug/9 mm disc after 24 hrs by disc diffusion method,Other,25891104.0,
30,1195601,1,1,,103355242,5955,Unspecified,,,,,Genotoxicity in rec-negative Bacillus subtilis M45 at 2 ug/9 mm disc after 24 hrs by disc diffusion method,Other,25891104.0,
31,1246389,1,1,,103355242,5955,Unspecified,,,,,Mutagenic activity in Salmonella typhimurium TA100 assessed as mutagenicity index at 40 ng/ml by Ames test,Other,26241874.0,
32,1246390,1,1,,103355242,5955,Unspecified,,,,,Mutagenic activity in Vibrio harveyi BB7 assessed as mutagenicity index at 40 ng/ml,Other,26241874.0,
33,1246391,1,1,,103355242,5955,Unspecified,,,,,Mutagenic activity in Vibrio harveyi BB7XM assessed as mutagenicity index at 40 ng/ml,Other,26241874.0,
